机构：[1]State Key Laboratory of Oncogenes and Related Genes, Center for Single-Cell Omics, School of Public Health, Shanghai Jiao Tong University School of Medicine, Shanghai, China.[2]Division of Digestive Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, GA, United States.[3]Center for IBD Research, Department of Gastroenterology, The Shanghai 10th People's Hospital, Tongji University, Shanghai, China.[4]Department of Gastroenterology, The Shanghai 10th People's Hospital, Department of Bioinformatics, School of Life Sciences and Technology, Tongji University, Shanghai, China.[5]Department of Gastroenterology,First Affiliated Hospital of Kunming Medical University,Yunnan Institute of Digestive Diseases,Kunming,China.内科科室外科科室消化内科普通外科普通外一科(胃肠与疝外科)昆明医科大学附属第一医院省级研究所云南省消化疾病研究所[6]Department of Gastroenterology, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, China.[7]Guangdong Institute of Gastroenterology, Guangdong Provincial Key Laboratory of Colorectal and Pelvic Floor Diseases, Department of Colorectal Surgery, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
第一作者机构：[1]State Key Laboratory of Oncogenes and Related Genes, Center for Single-Cell Omics, School of Public Health, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
通讯作者：
推荐引用方式(GB/T 7714)：
Liu Ning-Ning,He Peijian,Liu Zhanju,et al.Editorial: Microbiome in IBD: From Composition to Therapy, Volume II[J].FRONTIERS IN PHARMACOLOGY.2023,14:doi:10.3389/fphar.2023.1184269.
APA：
Liu Ning-Ning,He Peijian,Liu Zhanju,Zhu Ruixin,Miao Yinglei...&Zhu Lixin.(2023).Editorial: Microbiome in IBD: From Composition to Therapy, Volume II.FRONTIERS IN PHARMACOLOGY,14,
MLA：
Liu Ning-Ning,et al."Editorial: Microbiome in IBD: From Composition to Therapy, Volume II".FRONTIERS IN PHARMACOLOGY 14.(2023)
